GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
Understanding CHINAHONGQIAO (01378) 2025 Annual Performance in One Picture: Revenue Increased by 4% Year-on-Year, Continuous Optimization of Financial Structure.
New Stock News | Indonesia's MGR Files for Listing on Hong Kong Stock Exchange as One of Asia's Top Pure Gold Producers.
New stock news | PT Merdeka Gold Resources Tbk files for listing on the Hong Kong Stock Exchange
Understanding CHINAHONGQIAO (01378) 2025 Annual Performance in One Picture: Revenue Increased by 4% Year-on-Year, Continuous Optimization of Financial Structure.
New Stock News | Indonesia's MGR Files for Listing on Hong Kong Stock Exchange as One of Asia's Top Pure Gold Producers.
New stock news | PT Merdeka Gold Resources Tbk files for listing on the Hong Kong Stock Exchange
RECOMMEND
State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026
Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026
Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026
